A prospective randomized trial of a prophylactic plateletatransfusion trigger of 10 ¥ 109 per L versu
A UK single-centre survey of red cell antibodies
ABO-incompatible heart transplants
Blood transfusion practices in liver transplantation
Blood transfusions in kidney transplant¬andidates are comm
Blood Transfusions in Organ Transplant Patients_
Bloodless (transfusion-free) hematopoietic stem cell transplant
Clinical factors affecting engraftment and transfusion need
Induction of pre-transplant Epstein^«arr virus (EBV) infection by donor«lood transfusion in EBV^
Risk factors and outcomes of massive red blood cell
Liver Transplantation without Perioperative TransfusionsaSingle-Center Experience Showing Better Early Outcome
Infusion of Hematopoietic Stem Cells_ Types, Characteristics,ªdverse and Transfusion Reactions and the Implications for Nursing
Now Incidence of Hyperfibrinolysis
Perioperative blood transfusion affects hepatitis C virus
Peri-operative third party red blood cell transfusion in renal transplantation
Perioperative use of allogenic blood¬omponents in live-related donor
Plasma transfusion in liver transplantation_ a randomized,
Preoperative predictors of blood¬omponent transfusion
Profound thrombocytopenia and survival of hematopoietic stem
Prophylactic red blood cell exchange for ABO-mismatched
Red blood cell and leukocyte alloimmunization in patients awaiting kidney transplantation
Red-blood-cell alloimmunization and female sex predicta
Regulation of immune responses by RBC transfusion
Relationship of CD34+ cells infused and red blood cell
SCT in Jehovah’s Witnesses_ the bloodless transplant
Solvent detergent vs. fresh frozen plasma in cirrhotic
Associations of pre-transplant anemia
The association between red blood cell and platelet transfusion
The impact of perioperative transfusion of«lood products on survi
Transfusion has no effect on recurrence in hepatitis C
Transfusion policy_ when to stop the use of extremely rare blood
Transfusion-associated graft-versus-host disease in a liver
Transfusion-related Epstein-Barr virus infection among stem cell
Use of recombinant activated Factor VII for refracto
